Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
-0.66%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$17.3B
AUM Growth
+$1.23B
(+7.7%)
Cap. Flow
+$1.46B
Cap. Flow
% of AUM
8.46%
Top 10 Holdings %
Top 10 Hldgs %
15.93%
Holding
670
New
184
Increased
139
Reduced
131
Closed
125
Top Buys
| 1 |
Qualcomm
QCOM
|
$289M |
| 2 |
Apple
AAPL
|
$263M |
| 3 |
Charles Schwab
SCHW
|
$200M |
| 4 |
Jabil
JBL
|
$166M |
| 5 |
Meta Platforms (Facebook)
META
|
$165M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$269M |
| 2 |
Oracle
ORCL
|
$244M |
| 3 |
Estee Lauder
EL
|
$172M |
| 4 |
Dell
DELL
|
$160M |
| 5 |
Microsoft
MSFT
|
$136M |
Sector Composition
| 1 | Technology | 24.84% |
| 2 | Consumer Discretionary | 14.31% |
| 3 | Healthcare | 13.75% |
| 4 | Industrials | 12.21% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Booz Allen Hamilton
BAH
$12.6B
| $787K | ﹤0.01% |
+5,114
| New | +$787K |
|
452
Pool Corp
POOL
$12.4B
| $772K | ﹤0.01% |
+2,511
| New | +$772K |
|
453
Absci
ABSI
$368M
| $770K | ﹤0.01% |
250,000
-100,000
| -29% | -$308K |
|
454
IN8bio
INAB
$9.83M
| $764K | ﹤0.01% |
21,367
+6,500
| +44% | +$232K |
|
455
Kiora Pharmaceuticals
KPRX
$9.2M
| $759K | ﹤0.01% |
180,780
-63,664
| -26% | -$267K |
|
456
Kyverna Therapeutics
KYTX
$170M
| $675K | ﹤0.01% |
90,000
+25,000
| +38% | +$188K |
|
457
Expedia Group
EXPE
$26.6B
| $662K | ﹤0.01% |
+5,255
| New | +$662K |
|
458
Fractyl Health
GUTS
$65.4M
| $641K | ﹤0.01% |
150,000
| – | – |
|
459
Gain Therapeutics
GANX
$63.3M
| $576K | ﹤0.01% |
+450,000
| New | +$576K |
|
460
Werewolf Therapeutics
HOWL
$61.7M
| $575K | ﹤0.01% |
235,705
| – | – |
|
461
TransDigm Group
TDG
$71.6B
| $575K | ﹤0.01% |
450
-226
| -33% | -$289K |
|
462
Cytek Biosciences
CTKB
$511M
| $558K | ﹤0.01% |
100,000
| – | – |
|
|
GAUZ
463
Gauzy
GAUZ
$94.7M
| $554K | ﹤0.01% |
+46,105
| New | +$554K |
|
464
Tenable Holdings
TENB
$3.76B
| $545K | ﹤0.01% |
+12,512
| New | +$545K |
|
465
Alto Neuroscience
ANRO
$99.4M
| $535K | ﹤0.01% |
50,000
+40,000
| +400% | +$428K |
|
466
Applovin
APP
$166B
| $475K | ﹤0.01% |
5,712
-317
| -5% | -$26.4K |
|
467
Legend Biotech
LEGN
$6.66B
| $466K | ﹤0.01% |
+10,513
| New | +$466K |
|
468
Elutia
ELUT
$79.7M
| $456K | ﹤0.01% |
+91,977
| New | +$456K |
|
|
VBIV
469
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $402K | ﹤0.01% |
608,604
-17,832
| -3% | -$11.8K |
|
|
OTLY
470
Oatly Group
OTLY
$524M
| $347K | ﹤0.01% |
18,484
| – | – |
|
471
Hyperfine
HYPR
$91.9M
| $319K | ﹤0.01% |
375,000
| – | – |
|
472
Extra Space Storage
EXR
$31.3B
| $317K | ﹤0.01% |
2,039
-161,273
| -99% | -$25.1M |
|
473
TPG
TPG
$8.64B
| $284K | ﹤0.01% |
+6,847
| New | +$284K |
|
474
Replimune Group
REPL
$494M
| $265K | ﹤0.01% |
+29,460
| New | +$265K |
|
475
Domino's
DPZ
$15.7B
| $262K | ﹤0.01% |
+508
| New | +$262K |
|